Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:50:53.384Z.
Calculation as of: 2026-10-06T18:50:53.384Z.
Quote observation: 2026-10-06T18:49:51.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 412370d08cb3fb7a3c2e4d636897a8ea9259835d42853a062d33098765049a4f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Canopy Growth Corporation
Market Cap
$375.55M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$377.23M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$379.16M
Free Cash Flow Yield
N/A
TTM Avg
13.37%
3Y Avg
10.70%
5Y Avg
10.70%
Market Cap
$379.14M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$382.59M
Free Cash Flow Yield
N/A
TTM Avg
0.08%
3Y Avg
0.08%
5Y Avg
3.89%
Market Cap
$358.04M
Free Cash Flow Yield
45.97%
TTM Avg
52.29%
3Y Avg
21.98%
5Y Avg
21.35%
Market Cap
$356.36M
Free Cash Flow Yield
N/A
TTM Avg
3.10%
3Y Avg
3.51%
5Y Avg
4.59%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $375.55M | N/A | N/A | N/A | N/A |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $377.23M | N/A | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $379.16M | N/A | 13.37% | 10.70% | 10.70% |
| YD Bio Limited Ordinary Shares (YDES)vs › | $379.14M | N/A | N/A | N/A | N/A |
| Zura Bio Limited (ZURA)vs › | $381.80M | N/A | N/A | N/A | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $382.59M | N/A | 0.08% | 0.08% | 3.89% |
| Opus Genetics, Inc. (IRD)vs › | $365.52M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $358.04M | 45.97% | 52.29% | 21.98% | 21.35% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $356.36M | N/A | 3.10% | 3.51% | 4.59% |
| REGENXBIO Inc. (RGNX)vs › | $394.45M | N/A | 11.28% | 11.28% | 6.55% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
